ClinicaliQ Trial Snapshot
- iCorMicA – Stratified Medicine in Angina — Recruiting • Non-phase study • Cardiology / Cardiovascular • NCT04674449.
- What is being tested: Stratified medical therapy guided by an adjunctive interventional diagnostic procedure (IDP) during invasive management of angina patients with known coronary artery disease, compared to standard care.
- Patient eligibility overview: Adults with established angina and coronary artery disease undergoing invasive coronary angiography, stratified based on diagnostic findings to receive tailored medical therapy protocols.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The iCorMicA study is a multicentre, prospective, randomised, double-blind, sham-controlled, parallel-group, end-point trial and registry. The investigators seek to determine whether stratified medical therapy guided by an adjunctive interventional diagnostic procedure (IDP) during the invasive management of patients with known or suspected angina but no obstructive coronary artery disease improves symptoms, wellbeing, cardiovascular risk and clinical outcomes.
Eligibility Snapshot
- : 1. Age ≥18 years. 2. A clinical plan for invasive coronary angiography. 3. Symptoms of angina (typical or atypical) according to the Rose- and/or Seattle Angina questionnaires. 4. Able to comply with study procedures. 5. Able to provide informed consent.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.